SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as anticipation builds for the imminent Phase 3 REGAL trial readout for its AML cancer drug, GPS, with the community highly optimistic about "curative" outcomes and a potential buyout given strong clinical signals and recent comments from the CEO. The stock is reaching multi-year highs amid heavy call option activity, suggesting investors are pricing in a successful outcome and a potential short squeeze.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as it secures a spot in the White House-backed eIPP for early U.S. air taxi operations and launches Uber Air services in Dubai, intensifying community discussion around its accelerating path to commercialization and FAA certification amidst strong partnerships and recent revenue beats.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is actively trending amid escalating geopolitical tensions involving Iran, with many speculating on significant market volatility and a potential surge for the ETF. Conversely, a strong contingent views UVXY as a 'widowmaker' ETF, advocating for shorting its spikes due to its inherent decay and structure.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is trending amidst intense volatility driven by escalating geopolitical tensions in the Middle East, with ongoing conflict impacting oil supply routes and leading to wildly fluctuating crude prices. The community is sharply divided between those anticipating a significant short squeeze in oil-related stocks and others warning of a rapid correction, especially following a recent stock offering.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is seeing a massive surge in trading volume and share price, driven by a recently announced $40 million private placement. The community is actively debating the implications of this offering, with some anticipating a short squeeze and others questioning the sustainability of its current valuation compared to the offering price.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the Design Automation and Design IP segments. The Design Automation segment includes silicon design, verification of products and services, and Ansys products, and system integration of products and services. The Design IP segment refers to interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies primarily in the semiconductor and electronics industries. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Synopsys Inc

Synopsys is trending following NVIDIA's strategic investment and expanded partnership for AI engineering, though recent earnings, despite beating adjusted estimates, triggered a sell-off due to mixed guidance and concerns over organic growth and China exposure. The community remains divided, with many viewing the dip as a buying opportunity given Synopsys' critical role in chip design, while others express confusion over the volatility.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amidst strong anticipation for its Bankable Feasibility Study update, which many in the community believe will significantly re-rate the value of its heavy rare earth Tanbreez project. Geopolitical tensions are intensifying the conversation around the strategic importance of domestic critical mineral supply chains, positioning CRML as a key player in a sector poised for potential revaluation.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending amid intense community discussion around key technical 'golden cross' patterns, with many anticipating a significant price breakout after a period of sustained underperformance, while others predict further short-term dips before a potential rally.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending due to breakthrough ASH data for NXC-201, which showed high complete response rates in AL amyloidosis and led to an oversubscribed institutional offering. The community is buzzing about strategic hires signaling imminent BLA preparation, broader pipeline expansion into autoimmune diseases, and recent analyst coverage with significant price targets, all pointing to a potential re-rating as the company progresses through regulatory milestones.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is garnering significant attention following FedEx's integration into its Governing Council, fueling optimism for increased enterprise utility and adoption in supply chain solutions. This bullish sentiment is further amplified by anticipation for the Clarity Act to provide regulatory certainty, though some in the community express concerns about token dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BKI - Keep Black Knight and Suntory Beverage ( $STBFY ) stocks in the same portfolio. Next fiscal quarter end is on 30th of September 2023 https://www.macroaxis.com/competition/BKI/STBFY/Black-vs-Suntory #portfolio_prospective #better_portfolio #diversify

Find investment opportunities by comparing Black vs Suntory

Macroaxis

Black vs Suntory - Comparative Analysis | Macroaxis

dlvr.it

Black Knight Inc - Ordinary Shares - Class A

SUNTORY BEVERAG/ADR

 - Keep Black Knight and Suntory Beverage ( 

 ) stocks in the same portfolio. Next fiscal quarter end is on 30th of September 2023 